The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.1 - Manufacture of basic pharmaceutical products
600 jobs Number of planned job losses
Announcement Date
14 June 2012
Employment effect (start)
Foreseen end date
Description
On 14 June 2012 Danish pharmaceutical company Lundbeck announced plans to restructure its European operations in order to build a more flexible organisation and cut costs.
This decision is expected to result in 600 jobs being lost in the company's subsidiaries, mainly in Europe. According to the company representatives, the restructuring will not affect research and development units but will have impact on the company's sales divisions.
Lundbeck, which specialises in medications for brain disorders, operates in 57 countries, including production facilities in Italy, France and Denmark, and research centres in Denmark, China and the United States.
The timeline for the restructuring is to be announced.
Sources
14 June 2012: Børsen
Citation
Eurofound (2012), Lundbeck, Internal restructuring in European Union, factsheet number 73896, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/73896.